Metabolic syndrome and risks of colon and rectal cancer: The european prospective investigation into cancer and nutrition study

Cancer Prevention Research

Volumn 4, Issue 11, 2011, Pages 1873-1883

  Aleksandrova, Krasimira ^a   Boeing, Heiner ^a   Jenab, Mazda ^b   Bueno de Mesquita, H Bas ^c,d   Jansen, Eugene ^d   Van Duijnhoven, Fran̈zel J B ^c,d   Fedirko, Veronika ^b   Rinaldi, Sabina ^b   Romieu, Isabelle ^b   Riboli, Elio ^e   Romaguera, Dora ^e   Overvad, Kim ^f   Østergaard, Jane Nautrup ^f   Olsen, Anja ^g   Tjnøneland, Anne ^g   Boutron Ruault, Marie Christine ^h   Clavel Chapelon, Franco̧ise ^h   Morois, Sophie ^h   Masala, Giovanna ⁱ   Agnoli, Claudia ^j   Panico, Salvatore ^k   Tumino, Rosario ^l,m   Vineis, Paolo ^e   Kaaks, Rudolf ⁿ   Lukanova, Annekatrin ⁿ   Trichopoulou, Antonia ^o,p   Naska, Androniki ^o   Bamia, Christina ^o   Peeters, Petra H ^c   Rodriǵuez, Laudina ^q   Buckland, Genevieve ^r   Sańchez, Mariá José ^s   Dorronsoro, Miren ^t   Huerta, Jose Mariá ^u   Barricarte, Aurelio ^u,v   Hallmans, Gor̈an ^w   Palmqvist, Richard ^x   Khaw, Kay Tee ^y   Wareham, Nicholas ^z   Allen, Naomi E ^aa   Tsilidis, Konstantinos K ^aa   Pischon, Tobias ^a,ab   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f AARHUS UNIVERSITY   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

ⁱ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l CIVILE M P AREZZO HOSPITAL   (Italy)

^m HuGeF Foundation   (Italy)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^p HELLENIC HEALTH FOUNDATION   (Greece)

^q Health and Health Care Services Council   (Spain)

^r CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t Public Health Division of Gipuzkoa   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^w UMEÅ UNIVERSITY   (Sweden)

^x UMEÅ UNIVERSITY   (Sweden)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^aa UNIVERSITY OF OXFORD   (United Kingdom)

^ab MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COLON CANCER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS;

EID: 80053912033     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0218     Document Type: Article

References (27)

1. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-14. (Pubitemid 46135879)
2. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86:s836-42.
3. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL, Silaghi H, et al. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009;15:5141-8.
4. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31. (Pubitemid 44018922)
5. Rinaldi S, Rohrmann S, Jenab M, Biessy C, Sieri S, Palli D, et al. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2008;17: 3108-15.
6. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011;60:1094-102.
7. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36. (Pubitemid 43941640)
8. Bowers K Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006;164:652-64.
9. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:385-91. (Pubitemid 34408218)
10. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008;32:304-14. (Pubitemid 351271779)
11. Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the Physicians' Health Study. Cancer Epidemiol Biomarkers Prev 2006;15:2391-7. (Pubitemid 46048295)
12. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 2001;10:937-41. (Pubitemid 32844900)
13. Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:1-101.
14. Reaven G. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-47. (Pubitemid 44713049)
15. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 2006;83:1248-51. (Pubitemid 44713050)
16. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
19. Alberti KG, Zimmet P, Shaw JIDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
20. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika 1978;65:153-8. (Pubitemid 8308397)
21. Sundstrom J, Vallhagen E, Riserus U, Byberg L, Zethelius B, Berne C, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006;29:1673-4. (Pubitemid 44127603)
22. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42. (Pubitemid 37549610)
23. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007;115:1806-10; discussion 11.
24. Kahn R. Metabolic syndrome-what is the clinical usefulness? Lancet 2008;371:1892-3.
25. Simmons R, Alberti K, Gale E, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010;53:600-5.
26. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002;62:1030-5. (Pubitemid 34160283)
27. Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC, et al., Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 2006;11:370-82.